Pfizer reported first-quarter earnings that exceeded Wall Street expectations, leading to a slight increase in its stock price during premarket trading. The company also reaffirmed its financial guidance for the full year 2026, signaling confidence in its ongoing performance. This positive earnings report may boost investor confidence and influence Pfizer's stock movement in the near term.
Three well-known dividend stocks—Pfizer, UPS, and Chevron—are trading well below their five-year highs but continue to offer strong dividend yields of over 3.4% to 6.4%. Each company’s CEO has publicly committed to maintaining or growing dividends, s...
Pfizer is projected to increase 15.27% to $32.36 over the next 12 months, driven by a strong drug pipeline, raised revenue guidance, and a 6.19% dividend yield. Despite a recent $4.3 billion writedown and declines in COVID-related sales, Pfizer's new...
